Government regulations are reshaping the landscape of the medical disposables market, becoming a major driving force behind its anticipated growth. An increasing demand for effective healthcare measures has fueled a significant upsurge in this market. As per a recent survey by Future Market Insights, this market, valued at a notable US$153.5 billion in 2022, is projected to rise consistently at a Compound Annual Growth Rate (CAGR) of 7.1% from 2023 until 2033. By the end of 2033, the market size is expected to reach a staggering US$326.4 billion, indicating a flush opportunity for businesses and stakeholders in the sector.
Currently, bandages and wound dressings have seized the largest revenue share in this market, a trend that’s projected to extend with a CAGR of 6.8% from 2023 to 2033. This accentuates the intrinsic value of these basic healthcare supplies in everyday medical routines. The propellers of this robust market growth are identified as the increasing incidents of Hospital Acquired Infections, a surge in surgical procedures, and a rise in chronic diseases resulting in extended hospital admissions.
These factors have ignited a wave of growth in the emergency medical disposables sector. The medical disposables market is witnessing expansion due to an uprise in hospital-related illnesses and disorders along with an enhanced focus on infection prevention. HealthCare-Associated Infections, for instance, range from 3.5% to 12% in high-income countries and 5.7% to 19.1% in low and medium-income countries. A growing older population, increasing incidence of incontinence problems, the obligatory guidelines for patient safety in healthcare institutions, and heightened demand for sophisticated healthcare facilities are all fueling further growth in the medical disposables market.
The North American market, valued at US$ 61.7 billion in 2022, is set to reach a valuation of US$ 131 billion by 2033. This growth has been positively impacted by stringent FDA regulations implemented since August 2000, treating hospitals or third-party reprocesses as manufacturers, thus advocating higher accountability. Companies in this market, such as 3M, Johnson & Johnson Services, Inc., Abbott, Becton, Dickinson & Company, Medtronic, B. Braun Melsungen AG, Bayer AG, Smith and Nephew, Medline Industries, Inc., and Cardinal Health, have been actively involved in mergers, acquisitions, and partnerships, serving as key market players. The market analysis covers various segments including Surgical Instruments & Supplies, Infusion and Hypodermic Devices, Diagnostic & Laboratory Disposables, Bandages and Wound Dressings, Sterilization Supplies, Respiratory Devices, Dialysis Disposables, Medical & Laboratory Gloves, amongst others.